Bortezomib, a promising alternative for patients with refractory or relapsed thrombotic thrombocytopenic purpura after rituximab treatment.
作者信息
Yin Jie, Tian Hong, Kong Danqing, Li Yun, Gu Chengyuan, Wang Zhaoyue, Wu Depei, Yu Ziqiang
机构信息
National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China.
出版信息
Br J Haematol. 2022 Nov;199(4):619-622. doi: 10.1111/bjh.18430. Epub 2022 Sep 8.
PMID:36076349
Abstract
摘要
Zotero 插件